Payment overview · 2025
General Payments
$122,415.89
17 reported records · 4 companies
Healthcare provider profile · identity verified
Atul Verma, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · STOCKTON, CA · NPI 1093027989
Verified facts
What the public records show
CMS Open Payments records show Atul Verma, M.D. received $122,415.89 in general payments during 2025 across 17 reported records.
Boston Scientific Corporation accounted for 89.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $109,650.77 | 89.6% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $12,409.49 | 10.1% | 12 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$252.12 | 0.2% | 3 | 2025 |
| CardioFocus, Inc. | Unresolved — no canonical attribution shown | $103.51 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Acquisitions | $109,650.77 | 1 |
| Consulting Fee | $8,326.54 | 1 |
| Travel and Lodging | $4,232.65 | 12 |
| Food and Beverage | $205.93 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $109,650.77 | 1 | 2025 |
Source payment records
|
|||||
| TACTICATH ABLATION CATHETER, SENSOR ENABLED Normalized: tacticath ablation catheter sensor enabled |
Device | Abbott Laboratories | $8,359.08 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1864 | 230 |
| Furosemide | Furosemide | 1528 | 166 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1280 | 114 |
| Gabapentin | Gabapentin | 1206 | 118 |
| Amlodipine Besylate | Amlodipine Besylate | 1057 | 127 |
| Eliquis | Apixaban | 1030 | 124 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 900 | 104 |
| Trazodone Hcl | Trazodone Hcl | 877 | 80 |
| Metoprolol Tartrate | Metoprolol Tartrate | 797 | 96 |
| Tamsulosin Hcl | Tamsulosin Hcl | 742 | 81 |
| Mirtazapine | Mirtazapine | 678 | 73 |
| Carvedilol | Carvedilol | 636 | 73 |
| Potassium Chloride | Potassium Chloride | 589 | 72 |
| Pantoprazole Sodium | Pantoprazole Sodium | 582 | 103 |
| Lisinopril | Lisinopril | 580 | 77 |
| Sertraline Hcl | Sertraline Hcl | 572 | 68 |
| Donepezil Hcl | Donepezil Hcl | 505 | 39 |
| Lorazepam | Lorazepam | 490 | 71 |
| Quetiapine Fumarate | Quetiapine Fumarate | 489 | 60 |
| Losartan Potassium | Losartan Potassium | 476 | 65 |
| Divalproex Sodium | Divalproex Sodium | 451 | 47 |
| Levetiracetam | Levetiracetam | 451 | 56 |
| Metformin Hcl | Metformin Hcl | 436 | 51 |
| Famotidine | Famotidine | 435 | 52 |
| Buspirone Hcl | Buspirone Hcl | 398 | 48 |
| Escitalopram Oxalate | Escitalopram Oxalate | 394 | 39 |
| Hydralazine Hcl | Hydralazine Hcl | 385 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 340 | 37 |
| Olanzapine | Olanzapine | 317 | 27 |
| Amiodarone Hcl | Amiodarone Hcl | 298 | 37 |
| Baclofen | Baclofen | 298 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 298 | 27 |
| Simvastatin | Simvastatin | 272 | 18 |
| Jardiance | Empagliflozin | 271 | 39 |
| Midodrine Hcl | Midodrine Hcl | 269 | 38 |
| Memantine Hcl | Memantine Hcl | 266 | 19 |
| Benztropine Mesylate | Benztropine Mesylate | 238 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 234 | 15 |
| Tramadol Hcl | Tramadol Hcl | 218 | 33 |
| Prednisone | Prednisone | 210 | 36 |
| Spironolactone | Spironolactone | 203 | 35 |
| Omeprazole | Omeprazole | 202 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 201 | 41 |
| Clonazepam | Clonazepam | 194 | 22 |
| Xarelto | Rivaroxaban | 191 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 187 | 62 |
| Glipizide | Glipizide | 183 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 164 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 164 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 162 | 16 |
| Clonidine Hcl | Clonidine Hcl | 160 | 19 |
| Enulose | Lactulose | 147 | 36 |
| Pregabalin | Pregabalin | 147 | 20 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 139 | suppressed |
| Bumetanide | Bumetanide | 137 | 17 |
| Latanoprost | Latanoprost | 136 | 27 |
| Sevelamer Carbonate | Sevelamer Carbonate | 136 | 15 |
| Morphine Sulfate Er | Morphine Sulfate | 132 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 131 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 129 | 17 |
| Lamotrigine | Lamotrigine | 125 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 120 | 24 |
| Risperidone | Risperidone | 120 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 114 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 112 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 109 | 32 |
| Paroxetine Hcl | Paroxetine Hcl | 106 | suppressed |
| Ezetimibe | Ezetimibe | 105 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 105 | 42 |
| Citalopram Hbr | Citalopram Hydrobromide | 100 | 15 |
| Alendronate Sodium | Alendronate Sodium | 96 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 95 | 12 |
| Calcium Acetate | Calcium Acetate | 91 | suppressed |
| Aripiprazole | Aripiprazole | 90 | 17 |
| Alprazolam | Alprazolam | 89 | 12 |
| Folic Acid | Folic Acid | 89 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | 13 |
| Terazosin Hcl | Terazosin Hcl | 88 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 88 | 11 |
| Propranolol Hcl | Propranolol Hcl | 87 | suppressed |
| Finasteride | Finasteride | 85 | 27 |
| Atenolol | Atenolol | 81 | suppressed |
| Allopurinol | Allopurinol | 80 | 21 |
| Diazepam | Diazepam | 80 | suppressed |
| Insulin Lispro | Insulin Lispro | 75 | 34 |
| Oxycontin | Oxycodone Hcl | 73 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 46 |
| Levofloxacin | Levofloxacin | 70 | 41 |
| Albuterol Sulfate | Albuterol Sulfate | 69 | 44 |
| Humalog | Insulin Lispro | 69 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 37 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 67 | 41 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 27 |
| Celecoxib | Celecoxib | 66 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 65 | 28 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 65 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 65 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 62 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 61 | 16 |
| Lactulose | Lactulose | 60 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 58 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 58 | suppressed |
| Nifedipine Er | Nifedipine | 57 | suppressed |
| Tradjenta | Linagliptin | 55 | suppressed |
| Cephalexin | Cephalexin | 54 | 42 |
| Permethrin | Permethrin | 54 | 34 |
| Phenobarbital | Phenobarbital | 54 | suppressed |
| Primidone | Primidone | 54 | suppressed |
| Gemtesa | Vibegron | 53 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 53 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | 12 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 52 | suppressed |
| Nystatin | Nystatin | 51 | 27 |
| Warfarin Sodium | Warfarin Sodium | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 45 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | 17 |
| Meloxicam | Meloxicam | 44 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 44 | 14 |
| Lithium Carbonate | Lithium Carbonate | 43 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 43 | 28 |
| Dicyclomine Hcl | Dicyclomine Hcl | 42 | suppressed |
| Anastrozole | Anastrozole | 41 | suppressed |
| Budesonide | Budesonide | 41 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Haloperidol | Haloperidol | 40 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 39 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 39 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 39 | 32 |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 38 | 28 |
| Bupropion Hcl Sr | Bupropion Hcl | 37 | suppressed |
| Ketoconazole | Ketoconazole | 37 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 28 |
| Methimazole | Methimazole | 36 | suppressed |
| Mupirocin | Mupirocin | 36 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 27 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 25 |
| Topiramate | Topiramate | 34 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 34 | suppressed |
| Zonisamide | Zonisamide | 34 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 33 | suppressed |
| Clonidine | Clonidine | 32 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 32 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 31 | suppressed |
| Ertapenem | Ertapenem Sodium | 31 | 16 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | suppressed |
| Novolog | Insulin Aspart | 30 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 28 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 28 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 21 |
| Sulfasalazine | Sulfasalazine | 27 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Dextroamphetamine Sulfate | Dextroamphetamine Sulfate | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | suppressed |
| Ramipril | Ramipril | 26 | suppressed |
| Brilinta | Ticagrelor | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 25 | 11 |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 24 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Cilostazol | Cilostazol | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | 12 |
| Phenytoin | Phenytoin | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Levetiracetam Er | Levetiracetam | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Nystop | Nystatin | 20 | 16 |
| Scopolamine | Scopolamine | 20 | suppressed |
| Valproic Acid | Valproic Acid | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 19 | suppressed |
| Fluconazole | Fluconazole | 18 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 18 | 11 |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 18 | suppressed |
| Xifaxan | Rifaximin | 18 | suppressed |
| Austedo | Deutetrabenazine | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Erythromycin | Erythromycin Base | 17 | 13 |
| Fiasp | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Leflunomide | Leflunomide | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Clobazam | Clobazam | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | 11 |
| Insulin Aspart | Insulin Aspart | 16 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 16 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 12 |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Ingrezza | Valbenazine Tosylate | 15 | suppressed |
| Levemir | Insulin Detemir | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Paliperidone Er | Paliperidone | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 15 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Clozapine | Clozapine | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 12 | suppressed |
| Linezolid | Linezolid | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 12 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 12 | suppressed |
| Olanzapine Odt | Olanzapine | 12 | suppressed |
| Prilosec | Omeprazole Magnesium | 12 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Fluticasone-Salmeterol Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Perphenazine | Perphenazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $122,415.89 · 17 records | Boston Scientific Corporation | General - Therapies, TACTICATH ABLATION CATHETER, SENSOR ENABLED | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error